Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Imanova has signed an agreement that grants the company the right to manufacture for distribution and on-site use [18F]MK-6240, an early stage investigational PET imaging agent.
read more
Wednesday, August 29, 2018
ImaginAb and CPDC announced they have entered into a development and manufacturing agreement for the supply of ImaginAb's clinical-phase PET imaging agent Zr-89 IAB22M2C to key global geographies.
read more
Monday, September 25, 2017
ImaginAb announced a collaboration with Boehringer Ingelheim to further develop ImaginAb's CD8 T Cell imaging technology.
read more
Friday, February 16, 2018
ImaginAb announced the appointment of Ian Wilson as the company’s Chief Operating Officer.
read more
Friday, February 26, 2016
ImageIQ, an Imaging Software and Contract Research Organization supporting preclinical research and clinical trials, have formally announced a memorandum of understanding with T3 Labs, an Atlanta-based provider of biomedical preclinical testing and ...
read more
ImaBiotech Group announced the creation of an innovative global bioanalytical CRO with Pyxant Labs Inc. Colorado Springs and Salt Lake City sites. The integration of the expertise, innovation and analytical platforms of the companies to form a ...
read more
Tuesday, January 13, 2026
IMA Life announced its support of Sharp Sterile Manufacturing as part of its recent $28 million expansion of the Lee, Massachusetts facility. This strategic investment includes the installation of a fully automated IMA Life isolated filling line for ...
read more
Wednesday, October 08, 2025
The IMA Group has announced its acquisition of Chicago Research Center (CRC), a move that expands the company’s clinical trial footprint and marks its entry into dedicated sleep research.
read more
Illumina and Pacific Biosciences of California have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018.
read more
Iktos announced a collaboration agreement with Merck KGaA, Darmstadt, Germany, where Iktos generative modelling AI will be used to facilitate discovery and design of compounds for Merck KGaA.
read more
Wednesday, October 14, 2020
Iksuda has executed its option to secure exclusive, worldwide rights to develop a novel class of tumor-activated prodrug payloads from the University of Goettingen.
read more
Thursday, January 11, 2018
IKA Works is now 3-A CIP certified for the company’s High Shear Mixer, Multiple Stage Homogenizer and Solid-Liquid Disperser.
read more
IKA Works is now officially 3-A CIP certified for our High Shear Mixer, Multiple Stage Homogenizer and Solid-Liquid Disperser.
read more
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced that it has received tentative approval from the U.S. Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) ...
read more
Monday, November 11, 2013
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has received formal approval from the U.S. Food and Drug Administration (FDA) of its supplemental filing for the site transfer of ...
read more